Janux Therapeutics Inc (JANX)
56.77
+0.06
(+0.11%)
USD |
NASDAQ |
Dec 23, 16:00
56.77
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Free Cash Flow: -37.82M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rezolute Inc | -62.80M |
| Vir Biotechnology Inc | -473.07M |
| Cytokinetics Inc | -407.05M |
| Galectin Therapeutics Inc | -33.68M |
| Spero Therapeutics Inc | -17.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.231M |
| Cash from Investing (Quarterly) | 12.67M |
| Cash from Financing (Quarterly) | 1.649M |
| Free Cash Flow Per Share (Quarterly) | -0.0413 |
| Free Cash Flow to Equity (Quarterly) | -2.256M |
| Free Cash Flow Yield | -1.30% |